EP Wealth Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$353K Buy
675
+66
+11% +$31.5K ﹤0.01% 1075
2025
Q4
$355K Buy
+609
New +$311K ﹤0.01% 1040
2025
Q2
Sell
-604
Closed -$200K 1452
2025
Q1
$200K Buy
+604
New +$198K ﹤0.01% 1134
2022
Q4
Sell
-13,862
Closed -$901K 635
2022
Q3
$901K Hold
13,862
0.02% 243
2022
Q2
$992K Hold
13,862
0.02% 262
2022
Q1
$1.36M Sell
13,862
-1,540
-10% -$130K 0.03% 236
2021
Q4
$1.3M Buy
15,402
+10,106
+191% +$830K 0.03% 228
2021
Q3
$423K Hold
5,296
0.01% 362
2021
Q2
$516K Hold
5,296
0.01% 332
2021
Q1
$619K Hold
5,296
0.02% 286
2020
Q4
$589K Buy
+5,296
New +$647K 0.02% 240

Other funds holding MDGL